The Utilization of Medication for Opioid Use Disorder in an Outpatient Setting-View Presentation Slides

View Presentation Slides

Pdf Summary

The document summarizes a webinar hosted by the American Psychiatric Association on the use of Medication for Opioid Use Disorder (MOUD) in outpatient settings. Key points include the alarming rise in opioid-related overdose deaths, particularly among individuals aged 25-54, as well as the importance of addressing co-morbid psychiatric conditions such as anxiety, depression, bipolar disorder, and schizophrenia in those suffering from Opioid Use Disorder (OUD).<br /><br />The presentation was led by Dr. Joseph E. Mathias, outlining the benefits and challenges of different MOUD options - methadone, buprenorphine, and naltrexone - which are critical to maintaining recovery and preventing relapse and associated harms like Hepatitis C and endocarditis. Additionally, the document emphasizes the importance of properly assessing co-occurring mental health conditions to provide integrated and effective treatment.<br /><br />MOUD has proven to increase abstinence and improve treatment retention. Methadone acts as a full opioid agonist requiring regulated clinic visits, while buprenorphine, approved for office-based treatment, acts as a partial agonist allowing greater flexibility. Naltrexone functions as an antagonist, blocking opioid effects.<br /><br />Assessment tools such as the Clinical Opiate Withdrawal Scale and the Physician Drug Monitoring Program, along with interventions like naloxone for overdose reversal, are highlighted as essential components of a comprehensive management strategy. <br /><br />The webinar also tackled stigma around substance use, urging the use of less judgmental language, and encouraged participation in upcoming educational opportunities. Lastly, it outlined how to claim educational credit for participation and highlighted resources available for continued learning and professional development in managing serious mental illness and opioid use disorder.

Keywords

Opioid Use Disorder

Medication for Opioid Use Disorder

MOUD

opioid overdose deaths

co-morbid psychiatric conditions

methadone

buprenorphine

naltrexone

mental health assessment

substance use stigma